Skip to main content

Table 2 The laboratory and clinical characteristics of the patients based on the adequacy of hemodialysis as measured by Kt/V

From: Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease

Variable

Adequate hemodialysis N = 45

Inadequate hemodialysis N = 37

P-value

Kt/V

1.31 ± 0.96

0.98 ± 0.09

0.046

Age, years

49.8 ± 20.6

57.9 ± 16.6

0.057

ESA (epoetin alpha) (IU/Week)

7176.4 ± 2823.6

9155.0 ± 2844.3

0.002

Serum creatinine (μmol/L)

778.0 ± 274.1

776.3 ± 277.0

0.978

G6PD activity level (U/g Hb)

9.2 ± 0.7

5.7 ± 0.7

<0.005

Diabetic patients, n (%)

21 (46.7%)

18 (48.7%)

0.965

Hematocrit

37.0 ± 6.0

28.4 ± 7.2

<0.005

Hemoglobin (g/dL)

12.0 ± 2.0

9.5 ± 2.4

<0.005

Reticulocyte count, %

1.9 ± 0.10

2.2 ± 0.3

<0.005

HD duration (months)

18,06 ± 14.66

15 ± 14.28

0.486